DANA ZABOROWSKI: Open Payments
NPI 1538155387 · LIVERPOOL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,912 in 32 payments from 15 companies in 2025. Trend: 2023 $6,010 · 2024 $7,420 · 2025 $2,912
Speaker / faculty: $2,200Food & beverage: $712
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $1,284 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $1,061 |
| BridgeBio Pharma, Inc. | 2 | $136 |
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| Merck Sharp & Dohme LLC | 3 | $59 |
| Boston Scientific Corporation | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| ABIOMED | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
Products named: JARDIANCE, Attruby, Kerendia, VERQUVO, WAINUA, WATCHMAN, LEQVIO, FARXIGA.
Industry payments across NY — which companies pay providers there.
